Aarti Drugs Ltd 2025 Annual Report with Sustainability Disclosures
Company: Aarti Drugs Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 135
The report describes FY 2024-25 as a shift from sustainability ambition to operational execution, highlighting Zero Liquid Discharge, co-generation, captive solar investment, and expanded environmental programmes. It reports consolidated revenue of ₹ 2,403.4 Crores and an EcoVadis Silver rating in the 89th percentile globally. The company also reports ₹ 443.45 lakhs of CSR spending, supporting initiatives in education, healthcare, infrastructure, water conservation, housing, and rural development.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.